Secreted factors from colorectal and prostate cancer cells skew the immune response in opposite directions

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lundholm, Marie ^a   Hägglöf, Christina ^a   Wikberg, Maria L ^a   Stattin, Pär ^a   Egevad, Lars ^b   Bergh, Anders ^a   Wikström, Pernilla ^a   Palmqvist, Richard ^a   Edin, Sofia ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CACO-2 CELL LINE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLASSIFICATION; COLORECTAL TUMOR; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NUCLEAR REPROGRAMMING; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATE TUMOR; SECRETION (PROCESS); TH1 CELL; TUMOR CELL LINE;

CACO-2 CELLS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELLULAR REPROGRAMMING; COLORECTAL NEOPLASMS; CYTOKINES; HUMANS; INFLAMMATION; LYMPHOCYTE COUNT; MACROPHAGES; MALE; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 84946058654     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15651     Document Type: Article

References (41)

1. Edin, S. et al. The distribution of macrophages with a m1 or m2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One 7, e47045 (2012
2. Forssell, J. et al. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13, 1472-1479 (2007
3. Lissbrant, I. F. et al. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 17, 445-451 (2000
4. Zhang, Q. W. et al. Prognostic significance of tumor-Associated macrophages in solid tumor: a meta-Analysis of the literature. PLoS One 7, e50946 (2012
5. Fridman, W. H., Pages, F., Sautes-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12, 298-306 (2012
6. Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11, 889-896 (2010
7. Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25, 677-686 (2004
8. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958-969 (2008
9. Ruffell, B., Affara, N. I. & Coussens, L. M. Differential macrophage programming in the tumor microenvironment. Trends Immunol 33, 119-126 (2012
10. Edin, S., Wikberg, M. L., Rutegard, J., Oldenborg, P. A. & Palmqvist, R. Phenotypic skewing of macrophages in vitro by secreted factors from colorectal cancer cells. PLoS One 8, e74982 (2013
11. Karin, N. The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J Leukoc Biol 88, 463-473 (2010
12. Algars, A. et al. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer 131, 864-873 (2012
13. Lackner, C. et al. Prognostic relevance of tumour-Associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch 445, 160-167 (2004
14. Zhou, Q. et al. The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 8, 13 (2010
15. Nonomura, N. et al. Infiltration of tumour-Associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer. BJU international 107, 1918-1922 (2011
16. Lanciotti, M. et al. The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy. BioMed research international 2014, 486798 (2014
17. Tidehag, V. et al. High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome. Eur J Cancer 50, 1829-1835 (2014
18. Halin, S., Rudolfsson, S. H., Van Rooijen, N. & Bergh, A. Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. Neoplasia 11, 177-186 (2009
19. Shimura, S. et al. Reduced infiltration of tumor-Associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 60, 5857-5861 (2000
20. Ong, S. M. et al. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. European journal of immunology 42, 89-100 (2012
21. Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A. & Bradding, P. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J 33, 118-126 (2009
22. Stout, R. D. et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175, 342-349 (2005
23. Rizzo, A., Pallone, F., Monteleone, G. & Fantini, M. C. Intestinal inflammation and colorectal cancer: a double-edged sword? World J Gastroenterol 17, 3092-3100 (2011
24. Jones, S. A. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175, 3463-3468 (2005
25. Ikushima, H. & Miyazono, K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10, 415-424 (2010
26. Heusinkveld, M. et al. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. J Immunol 187, 1157-1165 (2011
27. Ebelt, K. et al. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma. The Prostate 68, 1-10 (2008
28. Frey, D. M. et al. High frequency of tumor-infiltrating FOXP3(+ ) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 126, 2635-2643 (2010
29. Ladoire, S., Martin, F. & Ghiringhelli, F. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer immunology, immunotherapy: CII 60, 909-918 (2011
30. Ling, A., Edin, S., Wikberg, M. L., Oberg, A. & Palmqvist, R. The intratumoural subsite and relation of CD8 and FOXP3 T lymphocytes in colorectal cancer provide important prognostic clues. Br J Cancer 110, 2551-2559 (2014
31. Salama, P. et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27, 186-192 (2009
32. Davidsson, S. et al. CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+ ) regulatory T cells with respect to lethal prostate cancer. Mod Pathol 26, 448-455 (2013
33. Flammiger, A. et al. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer. Eur J Cancer 49, 1273-1279 (2013
34. Sfanos, K. S. et al. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res 14, 3254-3261 (2008
35. Hooper, L. V. & Macpherson, A. J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10, 159-169 (2010
36. Weber, B., Saurer, L. & Mueller, C. Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. Semin Immunopathol 31, 171-184 (2009
37. Miller, A. M. & Pisa, P. Tumor escape mechanisms in prostate cancer. Cancer immunology, immunotherapy: CII 56, 81-87 (2007
38. Hammarsten, P., Rudolfsson, S. H., Henriksson, R., Wikstrom, P. & Bergh, A. Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats. The Prostate 67, 573-581 (2007
39. Egevad, L., Granfors, T., Karlberg, L., Bergh, A. & Stattin, P. Prognostic value of the Gleason score in prostate cancer. BJU international 89, 538-542 (2002
40. Dahlin, A. M. et al. Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor. Mod Pathol 24, 671-682 (2011
41. Hornberg, E. et al. Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS One 6, e19059 (2011